![Ben Shepherd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ben Shepherd
Chief Executive Officer at Trestle Biotherapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert F. Baltera | M | 58 |
Trestle Biotherapeutics, Inc.
![]() Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | 4 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 1 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ben Shepherd
- Personal Network